Populating an economic model with health state utility values: moving toward better practice.
about
The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in FinlandTocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context.The cost-effectiveness of a theory-based online health behaviour intervention for new university students: an economic evaluation.Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisalExamining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample.Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins.A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden.Economic evaluation of Cardio inCode®, a clinical-genetic function for coronary heart disease risk assessmentCost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trial.Should all anticoagulated patients with head injury receive a CT scan? Decision-analysis modelling of an observational cohort.Estimating health state utility values for joint health conditions: a conceptual review and critique of the current evidence.Challenges in modelling the cost effectiveness of various interventions for cardiovascular disease.Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Estimating Health-State Utility Values in Kidney Transplant Recipients and Waiting-List Patients Using the EQ-5D-5L.Cost-effectiveness of Memory Assessment Services for the diagnosis and early support of patients with dementia in England.The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention-the impact of cardiovascular effects.Establishing benchmark EQ-5D-3L population health state utilities and identifying their correlates in Gansu Province, China.Cost-utility of self-managed computer therapy for people with aphasia.Generic and disease-specific estimates of quality of life in macular degeneration: mapping the MacDQoL onto the EQ-5D-3L.Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada.Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece.Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease.Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatment.Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS).Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation.The Cost-Effectiveness of Lowering Permissible Noise Levels Around U.S. Airports.The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study.Estimating Health State Utility Values for Comorbidities.Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care.The Use of Health State Utility Values in Decision Models.PCSK9 inhibitor valuation: A science-based review of the two recent models.The Trade-Off between Optimizing Flight Patterns and Human Health: A Case Study of Aircraft Noise in Queens, NY, USA
P2860
Q26779541-98245DC7-AEDD-40B2-B3A9-1636CE5FBB5AQ33962865-1750261C-5BF6-4EBB-AC8B-9B6F6138351CQ34100578-D8193919-26B8-4CE7-865B-B685EFC6AD28Q34333505-946F11A6-B795-4808-9598-11EBCFECE8C5Q34573847-42107F04-1B97-4866-A56A-0627C3AB1556Q35119071-4064A239-5DB8-44BD-9DEF-CD5BEC565389Q35194914-83BB0D29-CD0D-4548-9B71-9C9E280387A0Q35596050-65463B0D-FF77-4307-B671-0ABE18F516A7Q36363175-0104D58F-BD40-457B-83C9-9094E1CBE092Q37301010-68AAE5CF-F45B-4A60-847A-B2EE4034E299Q37312285-97046A88-E08C-495F-A352-5DE6050A3649Q37517041-2B74B6B2-1024-4B64-8894-A1856545B40DQ38038594-E62356F5-ACD6-4D14-A12E-09A898FD5C8DQ38205728-4A3751FC-454A-4CEB-8CD3-DCB88EDA35D4Q38675158-C37FD923-E91A-412A-B95A-5BA73E1EFC69Q38676864-C9859A6C-4395-4D20-AF5D-EF822C551AAFQ38722058-6E090661-652C-4021-A7A9-0D81CCF47595Q38723448-E37C5357-54C2-4646-91E7-01498684B9C0Q38737063-E895C8F7-E082-4C48-9839-8F3BC50F570DQ39304511-F19A99B9-495C-43F8-9AEB-431B6BCCABF1Q40436790-4FB32828-0D82-4F31-8809-C0900F625A74Q40891018-4B8EBA03-BE97-42BD-A0D4-4DC2534F3EE8Q41187128-EFBA65C6-6603-4F2C-8651-C5C5442849B1Q44255033-B86740EF-DF7A-4471-A4C5-526DE2511805Q44667805-09132B47-5B99-41F6-9214-1F8513543AA7Q45886106-19781DFE-2664-4A3B-8BB7-A5FD4EF4AF4AQ47120053-48712E7B-2E19-4AAE-A741-A1826DE0B997Q47133419-292E7B7B-2346-437A-AFB0-D5F3A3361167Q47279429-2AFC4874-8319-41C7-A051-256752BF0DC5Q47567338-53B24ADE-8D1C-4170-B56B-C5D95DE016F6Q47624902-F6DA4923-B9C6-4E9E-A375-67325EBB0494Q50100250-C1C6A76E-3A12-4F23-B837-1677066EDAC0Q50100257-C27C60FE-9C4A-4F1D-8A8D-0B5933B609CCQ50100263-02A09651-5FC6-4A3D-A942-E0D50A667345Q52364662-A84BC6A9-3361-49F0-82DF-F559E75788A2Q58776441-E3FFCF05-4A28-4A09-AA11-BF778A08BD6E
P2860
Populating an economic model with health state utility values: moving toward better practice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Populating an economic model w ...... moving toward better practice.
@en
Populating an economic model w ...... moving toward better practice.
@nl
type
label
Populating an economic model w ...... moving toward better practice.
@en
Populating an economic model w ...... moving toward better practice.
@nl
prefLabel
Populating an economic model w ...... moving toward better practice.
@en
Populating an economic model w ...... moving toward better practice.
@nl
P1433
P1476
Populating an economic model w ...... moving toward better practice.
@en
P2093
John E Brazier
Roberta Ara
P304
P356
10.1111/J.1524-4733.2010.00700.X
P577
2010-03-10T00:00:00Z